Carregant...
Review of the COVID-19 Risk in Multiple Sclerosis
The ongoing pandemic of the novel coronavirus of 2019 (COVID-19) has resulted in over 1 million deaths, primarily affecting older patients with chronic ailments. Multiple sclerosis (MS) patients have been deemed particularly vulnerable given their high rates of disability and increased susceptibilit...
Guardat en:
| Publicat a: | J Cell Immunol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8098748/ https://ncbi.nlm.nih.gov/pubmed/33959727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.33696/immunology.3.080 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|